Asylia Therapeutics Alternatives & Competitors
12 companies similar to Asylia Therapeutics — Innovative therapies reshaping immune responses against autoimmune, cancer, and...
Companies similar to Asylia Therapeutics
AnTolRx
Innovative therapies for autoimmune diseases through targeted immune-regulation using prop...
Granza Bio
Reprogramming Immunity for Target-Specific Medicines
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
ImmunOs Therapeutics AG
Novel human immunomodulatory proteins for cancer and autoimmune diseases with a specific r...
Schlieren, Switzerland
Rival Readout
Competing with Asylia Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
Abcuro, Inc
Developing immunotherapies for autoimmune diseases and cancer
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
Waltham, United States
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Santa Monica, United Stat...
Fate Therapeutics Inc.
Transforming the lives of patients with autoimmune diseases and cancer.
San Diego, United States
About Asylia Therapeutics
Asylia Therapeutics is making significant strides in the biotechnology sector with its commitment to developing cutting-edge immune-modulating therapies. Established in 2019 in Houston, Texas, the company is focused on transforming the treatment landscape for autoimmune conditions, cancer, and infectious diseases. The...
Domain parking
Individuals or businesses looking to acquire domain names
Biotech, Immune-modulating Therapies, Autoimmune Conditions, Cancer Immunotherapy, Infectious Diseases, Antigen Presentation, Drug Pipeline Development, Anti-tumor Responses, Innovative Therapies, Immune System Modulation, Biotechnology Advancement, Therapeutic Drug Development
B2B
Licensing, Performance Based, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Asylia Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Asylia Therapeutics on 1 Apr 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
